BridgeMD
Tests treatment safety and results for Cancer
Official title Efficacy of Auricular Pressure Beans with Electroacupuncture and Estazolam Treating Insomnia Caused by Cancer
ClinicalTrials.gov ID: NCT06859190
What this study is testing
What is estazolam 1-2 mg?
estazolam 1-2 mg is an investigational medicine, given as an once-daily pill taken by mouth, being studied as a potential treatment for cancer.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The core objectives of this study are to assess the short-term and long-term efficacy of auricular acupoint pressure beans combined with electroacupuncture and estazolam in the treatment of cancer-caused insomnia. The study aims to accurately compare the differences between this combination therapy and standard Western medicine in improving sleep quality and effectively alleviating anxiety and depression.
- Phase 3: a large, late-stage study
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- Age 18 and above.
- The diagnosis of a malignant solid tumor was confirmed by pathological examination.
- Clinically diagnosed cancer-caused insomnia with insomnia symptoms lasting more than 1 month, more than 3 or more times per week.
- An Insomnia Severity Index (ISI) score of 8 or higher and meets the criteria for insomnia disorder as defined in the Diagnostic and Statistical...
- No medications related to the treatment of insomnia have been used in the last 1 month.
You likely can't join if
- Irregular sleep-wake cycles in jobs with shift demands or due to inconsistent work schedules.
- Inadequately treated for another sleep disorder (e.g., sleep disorder disorders such as sleep apnea obstruction syndrome, restless leg syndrome...
- Received acupuncture or auricular pressure bean therapy within the past 3 months.
- Estimated life expectancy is ≥3 months.
- Have a history of severe allergies, especially to the drugs or treatments used in this study.
- History of severe mental illness with a current episode.
See the full eligibility criteria
- Age 18 and above.
- The diagnosis of a malignant solid tumor was confirmed by pathological examination.
- Clinically diagnosed cancer-caused insomnia with insomnia symptoms lasting more than 1 month, more than 3 or more times per week.
- An Insomnia Severity Index (ISI) score of 8 or higher and meets the criteria for insomnia disorder as defined in the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition.
- No medications related to the treatment of insomnia have been used in the last 1 month.
- No serious dysfunction of the heart, liver, kidneys or other vital organs.
- Patients volunteered to participate in this study and signed an informed consent form.
- Irregular sleep-wake cycles in jobs with shift demands or due to inconsistent work schedules.
- Inadequately treated for another sleep disorder (e.g., sleep disorder disorders such as sleep apnea obstruction syndrome, restless leg syndrome, etc.).
- Received acupuncture or auricular pressure bean therapy within the past 3 months.
- Estimated life expectancy is ≥3 months.
- Have a history of severe allergies, especially to the drugs or treatments used in this study.
- History of severe mental illness with a current episode.
- History of substance abuse or alcohol dependence.
The study team makes the final eligibility decision.
Where it's taking place
- Xining, Qinghai, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Xining, Qinghai, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.